Citadel Advisors - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164904. A total of 3 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2015$31,000
-20.5%
17,900
-2.7%
0.00%
Q3 2015$39,000
-87.1%
18,400
-70.0%
0.00%
Q2 2015$303,000
-33.7%
61,300
+5.0%
0.00%
Q1 2015$457,000
-30.0%
58,400
-45.8%
0.00%
-100.0%
Q4 2014$653,000
+271.0%
107,700
+160.1%
0.00%
Q3 2014$176,000
-76.3%
41,400
-65.5%
0.00%
-100.0%
Q2 2014$742,000
+85.5%
120,100
+95.3%
0.00%
Q1 2014$400,000
+61.9%
61,500
+40.1%
0.00%
Q4 2013$247,000
-44.1%
43,900
-39.0%
0.00%
-100.0%
Q3 2013$442,000
-29.5%
72,000
-32.8%
0.00%0.0%
Q2 2013$627,000107,2000.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 524,100$2,594,0000.04%
SIMPLEX TRADING, LLC 114$13,0000.00%
Citadel Advisors 61,300$303,0000.00%
View complete list of OREXIGEN THERAPEUTICS INC shareholders